Concomitant chemoradiotherapy using docetaxel, cisplatin, and 5-FU for patients with advanced hypopharyngeal cancer.

被引：0
|
作者：
Shiga, K. [1 ]
Ogawa, T. [1 ]
Kato, K. [1 ]
Asada, Y. [1 ]
Kobayashi, T. [1 ]
机构：
[1] Tohoku Univ Hosp, Sendai, Miyagi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e16029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16029
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU for the patients with advanced hypopharyngeal cancer: Second report.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Ogawa, Takenori
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Concomitant chemoradiotherapy using docetaxel, cisplatin, and 5-FU for the patients with advanced squamous cell carcinoma of the temporal bone
    Shiga, Kiyoto
    Katagiri, Katsunori
    Ogawa, Takenori
    Kato, Kengo
    Asada, Yukinori
    Kobayashi, Toshimitsu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU (TPF) for the patients with advanced squamous cell carcinoma of the head and neck.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawat, Shin-ichi
    Ikeda, Aya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Induction and concomitant chemoradiotherapy (CCRT) using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with stage IVB advanced head and neck cancer
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawa, Shin-ichi
    Tuchida, Kodai
    Kusaka, Takahiro
    Ohashi, Yu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Concomitant chemoradiotherapy using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with advanced sino-nasal squamous cell carcinoma.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawa, Shin-ichi
    Ikeda, Aya
    Tuchida, Kodai
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Comparison of neoadjuvant Chemoradiotherapy with Docetaxel/Cisplatin/5-FU or Cisplatin alone in locally-advanced Oral cancer
    Abu Jawad, J.
    Grehl, S.
    Poettgen, C.
    Pfoertner, R.
    Eberhardt, W.
    Gauler, T.
    Arnold, G.
    Mohr, C.
    Stuschke, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 100 - 100
  • [7] Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
    Sadighi, Sanambar
    Mohagheghi, Mohammad Ali
    Montazeri, Ali
    Sadighi, Zahra
    [J]. BMC CANCER, 2006, 6 (1)
  • [8] Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
    Sanambar Sadighi
    Mohammad Ali Mohagheghi
    Ali Montazeri
    Zahra Sadighi
    [J]. BMC Cancer, 6
  • [9] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    Bae, Woo Kyun
    Hwang, Jun Eul
    Shim, Hyun Jeong
    Cho, Sang Hee
    Lee, Joon Kyoo
    Lim, Sang-Chul
    Chung, Woong-Ki
    Chung, Ik-Joo
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 589 - 595
  • [10] Phase II study of docetaxel, cisplatin and 5-FU induction chemotherapy followed by concurrent chemoradiotherapy for advanced nasopharyngeal cancer
    Cho, S.
    Bae, W.
    Hwang, J.
    Shim, H.
    Lee, J.
    Lim, S.
    Chung, W.
    Chung, I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345